1. Home
  2. BEAT vs BAFN Comparison

BEAT vs BAFN Comparison

Compare BEAT & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • BAFN
  • Stock Information
  • Founded
  • BEAT 2015
  • BAFN 1999
  • Country
  • BEAT United States
  • BAFN United States
  • Employees
  • BEAT N/A
  • BAFN N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • BAFN Savings Institutions
  • Sector
  • BEAT Technology
  • BAFN Finance
  • Exchange
  • BEAT Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • BEAT 58.0M
  • BAFN 63.2M
  • IPO Year
  • BEAT 2021
  • BAFN N/A
  • Fundamental
  • Price
  • BEAT $1.79
  • BAFN $10.26
  • Analyst Decision
  • BEAT Buy
  • BAFN
  • Analyst Count
  • BEAT 1
  • BAFN 0
  • Target Price
  • BEAT $8.00
  • BAFN N/A
  • AVG Volume (30 Days)
  • BEAT 99.2K
  • BAFN 9.4K
  • Earning Date
  • BEAT 11-06-2025
  • BAFN 10-30-2025
  • Dividend Yield
  • BEAT N/A
  • BAFN 3.11%
  • EPS Growth
  • BEAT N/A
  • BAFN 100.65
  • EPS
  • BEAT N/A
  • BAFN 1.89
  • Revenue
  • BEAT N/A
  • BAFN $78,211,000.00
  • Revenue This Year
  • BEAT N/A
  • BAFN N/A
  • Revenue Next Year
  • BEAT $19.35
  • BAFN N/A
  • P/E Ratio
  • BEAT N/A
  • BAFN $5.43
  • Revenue Growth
  • BEAT N/A
  • BAFN 0.67
  • 52 Week Low
  • BEAT $0.91
  • BAFN $6.40
  • 52 Week High
  • BEAT $3.48
  • BAFN $19.75
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 60.65
  • BAFN 58.35
  • Support Level
  • BEAT $1.74
  • BAFN $9.91
  • Resistance Level
  • BEAT $2.03
  • BAFN $10.52
  • Average True Range (ATR)
  • BEAT 0.11
  • BAFN 0.45
  • MACD
  • BEAT 0.00
  • BAFN 0.19
  • Stochastic Oscillator
  • BEAT 40.00
  • BAFN 66.12

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: